Seattle, WA, United States of America

Jean-Luc VanderHeyden


Average Co-Inventor Count = 3.3

ph-index = 7

Forward Citations = 215(Granted Patents)


Company Filing History:


Years Active: 1988-1997

Loading Chart...
9 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Jean-Luc VanderHeyden

Introduction

Jean-Luc VanderHeyden is a prominent inventor based in Seattle, WA, known for his significant contributions to the field of medical diagnostics and therapy. With a total of nine patents to his name, VanderHeyden has made remarkable advancements in the use of radionuclide-labeled proteins and glycoproteins.

Latest Patents

VanderHeyden's latest patents include innovative compositions for diagnosis and therapy. One of his notable inventions involves metal-radionuclide-labeled proteins and glycoproteins, which are designed for diagnostic purposes. Additionally, he has developed chelated radionuclide compositions that can be conjugated to polypeptides and carbohydrates, enhancing their utility in medical applications. Another significant patent focuses on stable therapeutic radionuclide compositions, which include isotopes such as .sup.186 Re, .sup.188 Re, and .sup.131 I. These compositions are stably bound to proteinaceous targeting moieties, making them suitable for human in vivo administration. The use of stabilizing agents, particularly antioxidants like ascorbic acid, ensures that these therapeutic compositions maintain a stability level of at least 90% for extended periods.

Career Highlights

Throughout his career, VanderHeyden has worked with notable organizations, including Neorx Corporation and the University of Cincinnati. His work has been instrumental in advancing the field of radionuclide therapy and diagnostics, contributing to improved patient outcomes.

Collaborations

VanderHeyden has collaborated with esteemed colleagues such as Alan R. Fritzberg and Sudhakar Kasina, further enhancing the impact of his research and innovations.

Conclusion

Jean-Luc VanderHeyden's contributions to the field of medical diagnostics and therapy through his innovative patents have established him as a key figure in the industry. His work continues to influence advancements in radionuclide applications, showcasing the importance of innovation in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…